NEW YORK (GenomeWeb News) – New Delhi-based Super Religare Laboratories will distribute Rosetta Genomics’ three microRNA-based cancer tests in India, Saudi Arabia, Qatar, and United Arab Emirates, Rosetta said today.

SRL will send the samples from the four countries to Rosetta Genomics’ CLIA-certified lab in Philadelphia for analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.